The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial report of a phase I study of LY2510924 with idarubicin and cytarabine (IA) in relapsed/refractory (R/R) AML.
 
Prajwal Boddu
No Relationships to Disclose
 
Gautam Borthakur
No Relationships to Disclose
 
Kiran Naqvi
No Relationships to Disclose
 
William G. Wierda
Consulting or Advisory Role - Abbvie; Celgene; Emergent BioSolutions; Genentech/Roche; Genzyme; Gilead Sciences; GlaxoSmithKline/Novartis; Merck; Pharmacyclics; Sanofi
Research Funding - Abbvie; Acerta Pharma; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics
 
Prithviraj Bose
Honoraria - Incyte
Consulting or Advisory Role - Incyte
Research Funding - Celgene
Travel, Accommodations, Expenses - Incyte
 
Elias Jabbour
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Zeev Estrov
No Relationships to Disclose
 
Jan Andreas Burger
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Pharmacyclics; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Yesid Alvarado
No Relationships to Disclose
 
APRIL Deshmukh
No Relationships to Disclose
 
Ami Patel
No Relationships to Disclose
 
Antonio Cavazos
No Relationships to Disclose
 
Lina Han
No Relationships to Disclose
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Michael Andreeff
No Relationships to Disclose
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Stemline Therapeutics (Inst)